drugset / Trial / NCT06058962
Double Blind Trial in Children With Autism Spectrum Disorder
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study investigated the safe and efficacious use of suramin as a novel treatment for ASD by testing two suramin doses vs placebo
Timeline
- Start
- 2019-06-01
- Primary completion
- 2021-01-15
- Completion
- 2021-03-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | suramin | Small molecule | 10 mg/kg | Intravenous |
| Subject | suramin | Small molecule | 20 mg/kg | Intravenous |